Mutation detection kits in genome editing market to reach $2.1 billion by 2030 at 13.0% cagr, driven by rising prevalence of genetic disorders and need for precise genomic analysis.
Read More
Muscle relaxant drugs market to reach $7.43 billion by 2030 at 7.8% cagr, driven by increasing number of sports injuries and rising cases of musculoskeletal disorders.
Read More
Multivitamin capsules and tablets market to reach $40.6 billion by 2030 at 6.2% cagr, driven by increasing health consciousness among individuals and demand for preventive nutrition.
Read More
Multivalent vaccines market to reach $14.28 billion by 2030 at 9.4% cagr, driven by rising incidences of infectious diseases and increasing focus on broad-spectrum immunization.
Read More
Multiple sclerosis treatment market to reach $33.02 billion by 2030 at 4.7% cagr, driven by growing prevalence of neurological disorders and rising demand for long-term disease management solutions.
Read More
Multiple sclerosis drugs market to reach $61.43 billion by 2030 at 13.0% cagr, driven by strong support from government and non-government organizations funding research and treatment programs.
Read More
Multiple myeloma drugs market to reach $31.61 billion by 2030 at 6.7% cagr, driven by increasing prevalence of hematological cancer and growing demand for effective targeted therapies.
Read More
Multidrug resistant bacteria market to reach $18.77 billion by 2030 at 7.4% cagr, driven by increasing prevalence of infectious diseases.
Read More
Mucolipidosis ii market to reach $16.19 billion by 2030 at 3.5% CAGR, driven by rise in gene therapy, increased research and development activities, and growing number of clinical trials.
Read More
Mtor inhibitors market to reach $10.39 billion by 2030 at 6.2% CAGR, driven by rise in prevalence of kidney diseases.
Read More